Editing Ranbaxy Laboratories (section)

{{Short description|Defunct Indian pharmaceutical manufacturer}}
{{Use Indian English|date=September 2013}}
{{Use dmy dates|date=November 2020}}
{{Infobox company
| name = Ranbaxy Laboratories Limited
| logo = Ranbaxy Logo.svg
| logo_size = 
| caption = 
| image =
| trading_name =
| type = [[Subsidiary]]
| traded_as = 
| fate = Acquired by [[Sun Pharma]]
| predecessor = 
| successor = [[Sun Pharmaceuticals]]
| foundation = {{Start date|1961}}
| founders = Ranbir Singh <br/> Gurbax Singh
| defunct = {{End date and age|2014}}
| location_city = [[Gurgaon]], [[Haryana]]
| location_country = India
| locations = 
| area_served = 
| key_people = {{ubl|Arun Sawhney (CEO, Ranbaxy Laboratories)|Joji Nakayama(CEO, Daiichi Sankyo)}}
| industry = [[Pharmaceutical industry|Pharmaceuticals]]
| products = 
| services = 
| revenue = 
| operating_income = 
| net_income = 
| aum = <!-- Only used with financial services companies -->
| assets = 
| equity = 
| owner = 
| num_employees = 10,983 <small>(2012)</small><ref name="2012report">{{cite web|url=http://www.ranbaxy.com/wp-content/uploads/2013/03/ranbaxy_annual_report_2012.pdf|title=Annual Report 2012|publisher=Ranbaxy Laboratories Limited|url-status=dead|archive-url=https://web.archive.org/web/20131105153730/http://www.ranbaxy.com/wp-content/uploads/2013/03/ranbaxy_annual_report_2012.pdf|archive-date=5 November 2013}}</ref>
| parent = [[Sun Pharmaceuticals]]
| divisions = 
| subsid = 
| homepage = 
| footnotes = 
| intl = 
}}
'''Ranbaxy Laboratories Limited''' was an Indian multinational [[pharmaceutical]] company that was incorporated in India in 1961 and remained an entity until 2014. The company went public in 1973. Ownership of Ranbaxy changed twice over the course of its history.

In 2008, Japanese pharmaceutical company [[Daiichi Sankyo]] acquired a controlling share in Ranbaxy<ref name="BB20180611merger">{{cite web |last1=Matsuyama |first1=Kanoko |last2=Chatterjee |first2=Saikat |title=Daiichi to Take Control of Ranbaxy for $4.6 Billion (Update3) - Bloomberg |url=https://www.bloomberg.com/apps/news?pid=newsarchive&sid=aMiwVweIVD60&refer=japan |website=Bloomberg.com |publisher=Bloomberg LP |access-date=2018-08-11 |archive-url=https://web.archive.org/web/20141202122035/http://www.bloomberg.com/apps/news?pid=newsarchive&sid=aMiwVweIVD60&refer=japan |archive-date=2014-12-02 |date=11 June 2008}}</ref> and in 2014, [[Sun Pharma]] acquired 100% of Ranbaxy in an all-stock deal. The Sun Pharma acquisition brought all new management to Ranbaxy, which had been laden with controversy {{xref|(see: {{slink||Controversies}}, below)}}. Sun is the world's fifth largest specialty generic pharmaceutical company.<ref name="bp" />